Who is sponsoring NCT05964127?

NCT05964127 is sponsored by Eastman Dental Insitute and Hospital.

What drugs are being tested in NCT05964127?

Interventions in NCT05964127: Air flow device, Hand instruments, Access flap surgery.

What condition does NCT05964127 study?

NCT05964127 studies Peri-Implantitis and Systemic Inflammation.

Is NCT05964127 still recruiting?

NCT05964127 is currently status unknown. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05964127: LASSO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peri-implantitis and Systemic Inflammation

Status unknown NA Last updated 27 July 2023

What this trial tests

NA trial testing Air flow device in Peri-Implantitis and Systemic Inflammation in 138 participants. Status unknown.

Timeline

19 July 2023

Primary endpoint
31 July 2025

31 December 2025

Quick facts

Lead sponsor	Eastman Dental Insitute and Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	138
Start date	19 July 2023
Primary completion	31 July 2025
Estimated completion	31 December 2025
Sites	1 location across United Kingdom

Drugs / interventions tested

Air flow device
Hand instruments
Access flap surgery

Conditions studied

Peri-Implantitis and Systemic Inflammation — all drugs for Peri-Implantitis and Systemic Inflammation →

Sponsor

Eastman Dental Insitute and Hospital

Who can join

18 and older, any sex, with Peri-Implantitis and Systemic Inflammation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate the effects of peri-implantitis (a disease around dental implants) and its treatment at both local and systemic levels using clinical and biological parameters. One study with two parts which will run simultaneously. An initial observational study comparing cases and controls and a subsequent interventional study in which the cases will proceed to treatments and all participants will be followed up for 6 months.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peri-Implantitis and Systemic Inflammation

Currently open trials in the same condition.

NCT07104760 — Longitudinal Evaluation of Regenerative Treatment of Peri-implantitis Assited by Er,Cr:YSGG Laser: up to 10 Years Follow · active not recruiting

Other Eastman Dental Insitute and Hospital trials

Trials by the same sponsor.

NCT04668911 — Oral Health, Microbial Burden and COVID-19 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05964127 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eastman Dental Insitute and Hospital
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05964127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing